Jennifer L. Peers

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study

Neil Krishan Aggarwal, Kyle C. Molina, Laurel Beaty et al. · The Lancet Infectious Diseases · 2023 · 145 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase

Neil R. Aggarwal, Laurel Beaty, Tellen D. Bennett et al. · International Journal of Infectious Diseases · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5

Kyle C. Molina, Brandon Webb, Victoria Kennerley et al. · BMC Infectious Diseases · 2024 · 11 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5

Kyle C. Molina, Victoria Kennerley, Laurel Beaty et al. · International Journal of Infectious Diseases · 2023 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16